· Periodic Report
Q3 operating loss of KRW 4.5 billion on revenue of KRW 20.2 billion
In Q3, the company sold KRW 20.2 billion of goods and lost KRW 4.5 billion from its main business, versus a KRW 3.7 billion loss a year earlier.
183490 · KOSDAQ · Based on DART filings
2 total · 20 per page
· Periodic Report
In Q3, the company sold KRW 20.2 billion of goods and lost KRW 4.5 billion from its main business, versus a KRW 3.7 billion loss a year earlier.
· Report on Large Shareholdings
The stake of Bridget Lifescience Co.,LTD and 8 related parties in ENZYCHEM LIFESCIENCES CORPORATION stays at 21.61%. Related parties amended share-backed loans covering 9,831,255 shares.
Get app alerts for new disclosures from ENZYCHEM LIFESCIENCES CORPORATION.